Please login to the form below

abiraterone

This page shows the latest abiraterone news and features for those working in and with pharma, biotech and healthcare.

CHMP turns down BMS’ Opdivo/Yervoy for kidney cancer

The decision comes after a clinical study suggested that patients given Xofigo in combination with Zytiga (abiraterone acetate) and prednisone/prednisolone could be at risk of dying earlier and had more

Latest news

Daily Brief: NICE says no to Zytiga, Genentech and UK biotech sign microbiome deal

families. “We firmly believe that the clinical effectiveness demonstrated in the multinational, Phase 3 LATITUDE study, means that abiraterone plus ADT should be made available routinely to NHS patients that need
EMA starts review of Xtandi in non-metastatic prostate cancer

At the moment Xtandi - like longstanding rival Zytiga (abiraterone acetate) from Johnson &Johnson - is only prescribed for men with advanced CRPC that has spread and no longer responds to hormone therapy.
J&J’s Erleada first US drug for non-metastatic prostate cancer

momentum before Zytiga (abiraterone acetate) - its current blockbuster medicine for CRPC - faces generic competition in the US, which accounted for around half of the drug’s $2.5bn in sales in
PROSPER data reveal big Xtandi benefit in early-stage prostate cancer

At the moment Xtandi, in common with a rival therapy from Johnson &Johnson called Zytiga (abiraterone acetate), is only prescribed for men with advanced CRPC that has spread and no longer ... Pfizer’s chief operating officer Albert Bourla told analysts
EC expands Janssen’s prostate cancer drug reach

Janssen has chalked up a significant win in the European market following a ruling on its prostate cancer drug Zytiga (abiraterone acetate), receiving the go-ahead to add an earlier stage

More from news
Approximately 5 fully matching, plus 65 partially matching documents found.

Latest Intelligence

Deal Watch May 2016

outperforming J&J's Zytiga [abiraterone].
Taking a strategic approach

But in oncology Zytiga (abiraterone) was last year not recommended for an early use indication in final draft guidance from NICE, but that appraisal process is currently on hold after Janssen
Pharma deals during October 2013

AstraZeneca is focusing on developing its regional oncology portfolio as evidenced by the closure of a co-promotion deal with Janssen in Japan for Zytiga (abiraterone acetate), an innovative oral therapy
Interview: Cesar Rodriguez, Janssen

Janssen is developing its strengths in other areas too, and Rodriguez noted the company's recent developments in oncology, including the launch of abiraterone acetate for prostate cancer – it's “ a

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Healthcare PR Senior Account Manager: Salary TBC

Healthcare Advertising Account Manager / Senior AM / AD: Salary TBC

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Associate Scientific Director: Salary TBC

Senior Account Manager – Healthcare Advertising: Salary TBC

Senior Medical Writer: Salary is DOE

Healthcare PR Director: £100, 000 – £120, 000 benefits

Graduate Scientific Editor: DOE

Senior Writer, Healthcare Advertising, London: Excellent package

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Market Access Consultant - Greater Manchester: Negotiable

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Account Manager: Negotiable

Medical Writer - Creative and Scientific Projects: DOE

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Account Director - Digital: Great salary and benefits

Senior Training Manager - Surrey: Competitive Salary &Bonus

Account Director or Senior Account Director: Salary TBC

Account Director, Healthcare Advertising Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

Biopharma's Future: Made in China: The world’s second biggest pharma market is entering a new growth phase – but meeting its needs takes investment and expertise...
Solaris Health looks at the gene therapy revolution: Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....